MABWELL-B Proposes New Executive Director Appointments

Stock News
05/31

MABWELL-B (02493) has announced that its second-term board of directors was elected at the company's 2022 annual general meeting on April 27, 2023. The term for this board will run from June 21, 2023, to June 20, 2026. Following a review and recommendation by the nomination committee, the board has proposed the election of Mr. Tang Chunshan, Dr. Liu Datao, Dr. Wu Hai, and Mr. Hua Jun as executive directors. It also proposed the election of Mr. Qin Zhengyu, Mr. Zhou Rui, Ms. Li Fan, and Ms. Wang Fang as independent non-executive directors. Dr. Gui Xun is an executive director representing the staff and will also be a candidate for the staff representative director on the trade union committee, to be elected at an extraordinary general meeting. The election of a staff representative director does not require approval from the board or shareholders. Among the members of the second-term board, Mr. Hu Huiguo will step down and will not be a candidate for re-election as an executive director upon the expiry of his term. Mr. Wu Yufeng will step down and will not be a candidate for re-election as a non-executive director. Dr. Xu Qing and Dr. Zhao Qian will step down and will not be candidates for re-election as independent non-executive directors for the third-term board. Consequently, Mr. Hu Huiguo will no longer serve as a member of the ESG Committee but will remain as a deputy general manager of the company. Dr. Xu Qing will also no longer serve as a member of the Audit Committee, a member of the Remuneration and Appraisal Committee, the Chairman of the Nomination Committee, or a member of the Strategy Committee. Dr. Zhao Qian will also no longer serve as a member of the Audit Committee, the Chairman of the Remuneration and Appraisal Committee, a member of the Nomination Committee, or a member of the ESG Committee. The departures of Mr. Hu Huiguo, Mr. Wu Yufeng, Dr. Xu Qing, and Dr. Zhao Qian will take effect upon the election of the new directors at the extraordinary general meeting.

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10